Idorsia
Europe, Basel-Landschaft, Switzerland, Allschwil
Description
The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.
Investor Profile
Idorsia has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in Switzerland.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Post Ipo Equity (100%)
Country Focus
- Switzerland (100%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
